Immunology

Limited economic evidence for vitiligo treatments

(HealthDay)—The cost burden associated with vitiligo is high, although no evidence exists for the value of vitiligo treatments, according to a research letter published online Aug. 10 in the British Journal of Dermatology.

Oncology & Cancer

Immunity against melanoma is only skin deep

In a newly published study, researchers at Dartmouth's Norris Cotton Cancer Center find that unique immune cells, called resident memory T cells, do an outstanding job of preventing melanoma. The work began with the question ...

Genetics

Researchers identify genes related to vitiligo

For the past decade, Richard Spritz's lab at the University of Colorado Anschutz Medical Campus has been searching for potential causes of vitiligo, an autoimmune disease that gives rise to patches of white skin and hair.

Diseases, Conditions, Syndromes

Confetti-like depigmentation may predict vitiligo progression

(HealthDay)—Confetti-like depigmentation may be a marker of rapidly progressing vitiligo, according to a review published in the August issue of the Journal of the American Academy of Dermatology.

Diseases, Conditions, Syndromes

For vitiligo patient, arthritis drug restores skin color

A medication for treating rheumatoid arthritis has restored skin color in a patient suffering from vitiligo, according to dermatologists at Yale School of Medicine. The disfiguring condition is best known as the disease that ...

Diseases, Conditions, Syndromes

Vitiligo, alopecia areata may up atopic dermatitis risk

(HealthDay)—The prevalence of atopic dermatitis (AD) is higher among patients with vitiligo or alopecia areata (AA), according to research published online Dec. 3 in JAMA Dermatology.

page 3 from 4